title: Suppression of the indirect pathway of T cell reactivity by high doses of allopeptide.
abstract: T helper cells, which recognize allopeptides processed and presented by self APC, contribute to the generation of both cellular and humoral immune responses against allogeneic transplants. We have explored the hypothesis that the indirect T cell recognition pathway is initiated by soluble MHC antigens and that it can be suppressed by high doses of synthetic peptides corresponding to the dominant alloepitope. T cells from a DR11/7 responder were immunized in vitro with recombinant HLA-DR4 (rDR4). Experiments using partially overlapping synthetic peptides showed that the resulting T cell line (TCL) recognized a single dominant epitope mapping within residues 69-88 of the first domain of the DR4 molecule. In vitro immunization with synthetic allopeptides corresponding to other polymorphic regions, were unable to elicit T cell reactivity against rDR4, although at least one of these peptides (corresponding to residues 13-27) was immunogenic, behaving like a cryptic epitope. The rDR4-specific TCL expressed a limited TCR repertoire and provided help to autologous B cells for the production of specific antibodies. The T cell blastogenic response as well as the transcription and secretion of IL-4 (but not IL-2) was efficiently suppressed by high doses of the dominant allopeptide. These findings support the concept that selective immunointervention of indirect allorecognition can be achieved by use of high doses of antigen or TCR vaccination, as proposed for autoimmune diseases.
authors.affiliation: Department of Pathology, College of Physicians and Surgeons of Columbia University, New York 10032, USA.
authors.forename: Z
authors.initials: Z
authors.lastname: Liu
authors.forename: P E
authors.initials: PE
authors.lastname: Harris
authors.forename: A I
authors.initials: AI
authors.lastname: Colovai
authors.forename: E F
authors.initials: EF
authors.lastname: Reed
authors.forename: A
authors.initials: A
authors.lastname: Maffei
authors.forename: N
authors.initials: N
authors.lastname: Suciu-Foca
mesh_terms: D004306:Dose-Response Relationship, Immunologic; D000939:Epitopes / Q000276:immunology; D015804:HLA-DR4 Antigen / Q000494:pharmacology; D006801:Humans; D007108:Immune Tolerance; D005810:Multigene Family / Q000276:immunology; D010455:Peptides / Q000276:immunology* / Q000494:pharmacology; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics / Q000276:immunology; D012995:Solubility; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000939:Epitopes; D015804:HLA-DR4 Antigen; D010455:Peptides; D016693:Receptors, Antigen, T-Cell, alpha-beta